Health Supreme

Researchers at Imperial College London recently went to great lengths to obtain psilocybin and use it in clinical tests to investigate its medicinal value for treating severe depression.

It took 32 months for the research team to meet all the licensing requirements to even conduct the trial. They also commented that the price per dose was literally 50 times more than what it should have cost in a "sane world."

Twelve participants with severe depression signed up to receive high doses of the banned psilocybin. They were given capsules orally and monitored closely.

The medicinal properties of psilocybin were quickly realized. In just one week, all the participants were free of depression and self loathing. After three months, there were no lingering symptoms of depression whatsoever for five of the participants.

“Our findings indicate that CBD could represent a novel fast antidepressant drug, via enhancing both serotonergic and glutamate cortical signaling through a 5-HT1A receptor-dependent mechanism,” researchers wrote. 

Unfortunately, due to the schedule I status of cannabis it has been difficult to do studies on the subject of CBD and depression until recently. However, this could soon change if congress were to pass the CARERS Act, which would successfully remove cannabidiol from the controlled substances act all together, while also rescheduling cannabis from Schedule I to Schedule II – which is something scientists, doctors, and advocates of reform have been hoping to see for years now. 

The fact that CBD could be used as an effective treatment for depression – and that it could start helping patients feel better within an hour of starting treatment – is simply incredible in and of itself. There are millions of people suffering from depression in the United States alone – antidepressants can be dangerous, addictive and expensive for life-long treatment... 

(click on title for the whole article...)